Skip to main content
AVECHO BIOTECHNOLOGY LIMITED logo

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Open in API
Filings indexed 881 across all filing types
Latest filing 2015-04-16 Director's Dealing
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
Appendix 3X Notices - 3 7 pages 205.7KB
Director's Dealing Classification · 100% confidence The document is titled 'APPENDIX 3X NOTICES (INITIAL DIRECTOR’S NOTICE)' and contains detailed disclosures about the initial director's interests for three directors appointed on 13 April 2015. It references ASX listing rule 3.19A.1 and section 205G of the Corporations Act, which relate to director appointments and their securities interests. The content is focused on director appointments and their relevant securities interests, with no financial statements or company performance data. This matches the definition of Director's Dealing filings, which report personal share transactions or interests by company directors and executives. The document length is 9281 characters, sufficient for a detailed notice but not a full financial report. Therefore, the appropriate classification is DIRS (Director's Dealing).
2015-04-16 English
2014 Annual Report and 2015 AGM documentation 120 pages 5.0MB
Regulatory Filings
2015-04-16 English
Phosphagenics Appoints Three New Directors 2 pages 46.9KB
Board/Management Information Classification · 100% confidence The document is a company announcement from Phosphagenics Limited dated 13 April 2015, regarding the appointment of three new directors to the board. It details the backgrounds and qualifications of the new directors and includes quotes from the chairman. There is no financial data, no mention of a report or financial results, and the content focuses solely on changes in the company's board of directors. This fits the definition of Board/Management Information (MANG). The document length is 4359 characters, which is consistent with a typical announcement of this nature rather than a full report or presentation.
2015-04-12 English
Animal Health Nutrition License Agreement signed 2 pages 52.3KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Phosphagenics Limited regarding a license agreement to expand animal nutrition products to the UK and Ireland. It details the terms of the license, the parties involved, and the expected commercial impact. There are no financial statements, regulatory certifications, or detailed financial performance data. The document is a corporate announcement about a business development or commercial agreement rather than a financial report, management change, or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is best classified as a general regulatory announcement about a business agreement, which fits the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other specific categories.
2015-03-24 English
Response to ASX Price Query 4 pages 215.0KB
Regulatory Filings Classification · 100% confidence The document is a letter from ASX Compliance Pty Limited to Phosphagenics Limited regarding a price and volume query about the company's securities. It discusses compliance with ASX Listing Rules, specifically Listing Rule 3.1 and 3.1A, and addresses recent trading activity and disclosure obligations. The document is a regulatory communication related to market compliance and disclosure, not a financial report, earnings release, or other specific report type. It does not contain financial statements or detailed financial data but is a formal regulatory inquiry and response. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance-related documents that do not fit other categories.
2015-03-11 English
December 2014 Preliminary Final Report and Financial Report 70 pages 713.9KB
Regulatory Filings
2015-02-25 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.